Skip to main content

Genentech parent's Parkinson's drug trial fails with Bay Area partner

The second part of the study is ongoing but has been slowed by the COVID-19 pandemic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.